Your browser doesn't support javascript.
loading
Efficacy of PI3K inhibitors in advanced breast cancer.
Verret, B; Cortes, J; Bachelot, T; Andre, F; Arnedos, M.
  • Verret B; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
  • Cortes J; IOB Institute of Oncology, Quiron, Madrid & Barcelona; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona; Medica Scientia Innovation Research (MedSIR), Valencia, Spain; Medica Scientia Innovation Research (MedSIR), New York, USA.
  • Bachelot T; Medical Oncology Department, Centre Léon Bérard, Lyon.
  • Andre F; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; Inserm Unit U981, Gustave Roussy Cancer Campus, Villejuif; Université Paris Sud, Paris-Saclay, France.
  • Arnedos M; Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; Inserm Unit U981, Gustave Roussy Cancer Campus, Villejuif. Electronic address: monica.arnedos@gustaveroussy.fr.
Ann Oncol ; 30 Suppl 10: x12-x20, 2019 12.
Article en En | MEDLINE | ID: mdl-31928690
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase I / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Animals / Female / Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase I / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Animals / Female / Humans Idioma: En Año: 2019 Tipo del documento: Article